TY  - JOUR
AU  - Cattrini, Carlo
AU  - España, Rodrigo
AU  - Mennitto, Alessia
AU  - Bersanelli, Melissa
AU  - Castro, Elena
AU  - Olmos, David
AU  - Lorente, David
AU  - Gennari, Alessandra
PY  - 2021
DO  - 10.3390/cancers13184522
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/18557
T2  - Cancers
AB  - The treatment landscape of advanced prostate cancer has completely changed during the last decades. Chemotherapy (docetaxel, cabazitaxel), androgen-receptor signaling inhibitors (ARSi) (abiraterone acetate, enzalutamide), and radium-223 have...
LA  - en
KW  - LuPSMA
KW  - PARP inhibitors
KW  - androgen-receptor signaling inhibitors
KW  - chemotherapy
KW  - ipatasertib
KW  - metastatic castration-resistant prostate cancer
KW  - metastatic hormone-naïve prostate cancer
KW  - metastatic hormone-sensitive prostate cancer
KW  - nonmetastatic castration-resistant prostate cancer
TI  - Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer.
TY  - research article
VL  - 13
ER  -